Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-25-002531
Filing Date
2025-05-23
Accepted
2025-05-23 16:16:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 8427
  Complete submission text file 0000902664-25-002531.txt   10269
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 650-231-6625
ALUMIS INC. (Subject) CIK: 0001847367 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-94550 | Film No.: 25982510
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 PLEASANT STREET, SUITE 400 PORTSMOUTH NH 03801
Business Address 3 PLEASANT STREET, SUITE 400 PORTSMOUTH NH 03801 781-522-4912
AyurMaya Capital Management Company, LP (Filed by) CIK: 0001975990 (see all company filings)

EIN.: 873199952 | State of Incorp.: NH
Type: SCHEDULE 13D/A